search
Merck
Trends
- 1Analysts Argue WILLOW Trial Endpoint, Not Enpatoran, Failed●The WILLOW Trial Didn’t Fail Enpatoran. The Endpoint Did.
Commentary around Merck KGaA's enpatoran is challenging the framing of the WILLOW trial results, arguing the drug was not proven ineffective but that the trial's chosen endpoint failed to capture the treatment effect. The piece says the outcome measure, not the therapy itself, is what fell short, reigniting debate over how lupus clinical trials are designed and judged.
- 2Merck showcases new calf behavior monitoring technology▼Merck highlights new technology to monitor calf behavior
Merck is promoting a new technology designed to monitor calf behavior, aimed at helping farmers detect health or welfare issues earlier through automated observation. The company highlighted the system in an agricultural news feature, positioning it as part of growing interest in digital tools and precision monitoring in livestock farming.
- 3Merck Animal Health expands SenseHub dairy monitoring▼Merck Animal Health expands SenseHub dairy monitoring capability
Merck Animal Health has announced an expansion of the capabilities of its SenseHub dairy monitoring system, which tracks cow health, heat detection and reproductive status. The news, reported by Feedstuffs, signals the company's continued push into precision livestock technology aimed at improving dairy farm productivity and herd management.